INDUSTRY PROFILE
The vaccine industry was transformed by mRNA platforms and now pursues programmable, rapidly deployable immunizations. It maintains close ties to academic immunology and structural-biology labs, recruiting PhD scientists in antigen design and formulation.
MARKET SIZE
$70B
KEY COMPANIES
10
TARGET RESEARCHERS
Immunologists and molecular biologists in mRNA technology, antigen design, adjuvants, and immune profiling
KEY COMPANIES
USE CASES
mRNA-platform R&D recruitment
Academic antigen-design partnerships
University immunology collaborations
Vaccine-formulation talent pipeline
Pandemic-preparedness research alliances
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED